← back to search

Liming Cai

Sun Yat-sen University Cancer Center · CN
Area of research
Cancer Research · Biomedical Engineering
Research interest
Research focused on Cancer research and Wnt signaling pathway, with related work in Metastasis, Ovarian cancer, Catenin. Notable publications include 'CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype', 'Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular...', and 'Morroniside, a novel GATA3 binding molecule, inhibits hepatic stellate cells activation by enhancing lysosomal acid lipase expression'.
h-index
citations
222
works
7
NIH funding
primary concept
email

Recent publications

N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling
iScience 2024cited by 3position: middledoi
Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma
BMC Medicine 2023cited by 37position: middledoi
N6-Methyladenosine-Modified VGLL1 Promotes Ovarian Cancer Metastasis Through HMGA1/Wnt/β-Catenin Signaling
SSRN Electronic Journal 2023cited by 0position: middledoi
CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype
Journal for ImmunoTherapy of Cancer 2022cited by 163position: middledoi
Morroniside, a novel GATA3 binding molecule, inhibits hepatic stellate cells activation by enhancing lysosomal acid lipase expression
Phytomedicine 2022cited by 18position: middledoi
N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through HMGA1/Wnt/β-catenin signaling
Research Square 2022cited by 1position: middledoi
Lysosomal Acid Lipase, a Novel Biomarker for Hepatic Fibrosis
SSRN Electronic Journal 2021cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhongqiu Liu · Guangzhou University of Chinese Medicine6 papers (2021–2024)Desheng Weng · State Key Laboratory of Oncology in South China5 papers (2022–2024)Tong Xiang · Southwest Jiaotong University5 papers (2022–2024)Qiuzhong Pan · Shanghai Children's Medical Center5 papers (2022–2024)Yanna Zhang · Guangzhou University of Chinese Medicine4 papers (2022–2024)Jingjing Zhao · Fujian Normal University4 papers (2022–2024)Jian‐Chuan Xia · Sun Yat-sen University4 papers (2022–2024)Xingyu Jiang · Tongji University4 papers (2022–2024)Jia He · Fudan University3 papers (2022–2024)Mi Zhang · Central South University2 papers (2021–2022)Qijing Wang · Sun Yat-sen University Cancer Center2 papers (2023–2024)Yulong Han · Shandong University of Technology2 papers (2022–2023)Jieying Yang · Chongqing University2 papers (2022–2023)Chaopin Yang · Sun Yat-sen University Cancer Center2 papers (2022–2023)Yue Huang · Taipei Medical University2 papers (2022–2023)Tao Su · Guangzhou University of Chinese Medicine2 papers (2021–2022)Hiu Yee Kwan · University of California, Berkeley2 papers (2021–2022)Yan Tang · Qingdao University2 papers (2022–2023)Fengze Sun · Sun Yat-sen University2 papers (2022–2023)Lin An · Guangzhou University of Chinese Medicine2 papers (2021–2022)